Neuro-Oncology
The Pediatric Neuro-Oncology Program is an integral part of The Preston Robert Tisch Brain Tumor Center at Duke. Pediatric patients with brain and spinal tumors and their families are provided with comprehensive, coordinated care through research, clinical care, and support services.
We believe an interdisciplinary approach is required for quality care. Our team includes physicians, nurse practitioners, nurses, clinical researchers, social workers, neuropsychologists, chaplains, child life specialists, and hospital school teachers who are dedicated to caring for the needs of patients with brain tumors and their families.
We seek to improve the well-being and survival of children with brain tumors through advances in laboratory and clinical investigation, compassionate care, and enhanced quality of life.
Treatments
We offer treatments and services related to brain and spinal cord tumors, including experimental therapies through clinical trials. In addition, we offer the following programs and services to our patients and their families:
- The Brain Tumor Family Learning Center
- School Re-entry Assistance
- Educational programs, opportunities, materials
- Supportive counseling for children and adults
- Social work services
- Grief, loss, bereavement counseling
Commonly Performed Exams and Procedures
- Laboratory studies/blood work
- MRI and CT scans of brain and spine
- Lumbar punctures
- Infusaport and central line access
- Audiograms
- Neurological assessments
- Neuropsychological assessments
Physicians and Staff
Physicians
| Name | Areas of Special Interest |
|---|---|
| Oren J. Becher, MD | Central nervous system tumors in children and teenagers; new treatment regimens for children and young adults with gliomas; interest in discovering novel, highly targeted, potent, and less toxic molecular inhibitors to treat brain tumors, and in testing novel drugs in genetic models of brain-stem gliomas or DIPGs |
| Melanie J. Bonner, PhD | Pediatric psychology; patients and families coping with chronic illness; psychological assessment of children and adolescents with medical, developmental, learning, and/or behavioral problems |
| Sridharan Gururangan, MRCP (UK) | Developing innovative phase 1 and 2 trials in the treatment of children with recurrent brain tumors |
Staff
| Name | Role |
|---|---|
| Jeanne Krauser, RN, MSN, CPNP | Pediatric Nurse Practitioner |
| Jennifer King, RN, CPON | Clinical Research Coordinator |
| Rebecca McIntyre, MSW, LCSW | Pediatric Social Worker |
| Trish Peters | Hospital School Teacher |
| Tarah Buckner | Staff Assistant/Patient Coordinator |
Clinic Hours and Location
Our clinic is located on Level Four of the McGovern-Davison Children's Health Center.
Hours:
Monday, 9:00 am - 5:00 pm
Tuesday, 9:00 am - 5:00 pm
Thursday, 9:00 am - 1:00 pm
Appointments and Contact Information
Pediatric Neuro-Oncology Main Office: 919-668-6288
General and Appointment Related Questions
Medical Emergencies Anytime: 919-684-8111
Mailing Address:
Duke University Medical Center
Hanes House, Room 306
330 Trent Drive
Box 102382
Durham, NC 27710
Tel: 919-668-6288
Fax: 919-668-2485
Duke Children's Ranked for Top Pediatric Care
Nationally recognized by U.S. News & World Report as one of the best pediatric cancer programs, we are dedicated to innovative, compassionate and life-changing care for all children. [Learn more]
Duke Resources
Articles
- Pediatric Brain Tumor Foundation Gives $6 Million to Further Childhood Brain Tumor Research at Duke
- Tumor Suppressor Gene in Flies May Provide Insights for Human Brain Tumors
- Discovery Makes Brain Tumor Cells More Responsive to Radiation
- Animal Study Identifies Promising New Target for Brain Tumor Therapy
- Researchers Find Mechanism To Target Brain Tumor Cells
- Drug Combo Might Offer Hope for Some Brain Tumor Patients
- Chemotherapy May Enhance the Effectiveness of Brain Tumor Vaccines
- Drug Combination Might Offer Hope for Patients with Deadly Brain Tumors
- Vaccine May Double Survival in Patients with Deadly Brain Tumors
- Types of Brain Tumors
- Newly Discovered Gene Could Be a Prime Target in the Most Lethal Brain Cancer
- Cellular Target May Prove Useful in Treating Deadly Brain Tumors
- Bevacizumab (Avastin) May Improve Treatment Response in Patients With Newly Diagnosed Brain Cancer
- Key to Treating Cancer May Be Finding its Original Cell
Web Sites
Related Links
- National Brain Tumor Society
- Brain Tumor: National Cancer Institute
- Children's Brain Tumor Foundation
- Pediatric Brain Tumor Foundation
